Th17 cells coordinate with Th22 cells in maintaining homeostasis of intestinal tissues and both are depleted in SIV-infected macaques

Journal of AIDS and Clinical Research

Volumn 5, Issue 5, 2014, Pages

  Xu, Huanbin ^a   Wang, Xiaolei ^a   Veazey, Ronald S ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

HIV; Intestine; Mucosal immunology; SIV; T17; T22

Indexed keywords

EID: 84903305337     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.1000302     Document Type: Article

References (52)

1. Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, et al. (2008) Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodefciency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82: 538-545.
2. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, et al. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280: 427-431.
3. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
4. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, et al. (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200: 761-770.
5. Hartigan-O'Connor DJ, Hirao LA, McCune JM, Dandekar S (2011) Th17 cells and regulatory T cells in elite control over HIV and SIV. Curr Opin HIV AIDS 6: 221-227.
6. Xu H, Wang X, Liu DX, Moroney-Rasmussen T, Lackner AA, et al. (2012) IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol 5: 658-669.
7. Klatt NR, Estes JD, Sun X, Ortiz AM, Barber JS, et al. (2012) Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol 5: 646-657.
8. Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, et al. (2008) Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112: 2826-2835.
9. Paiardini M (2010) Th17 cells in natural SIV hosts. Curr Opin HIV AIDS 5: 166-172.
10. Ciccone EJ, Greenwald JH, Lee PI, Biancotto A, Read SW, et al. (2011) CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. J Virol 85: 5880-5888.
11. Macal M, Sankaran S, Chun TW, Reay E, Flamm J, et al. (2008) Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specifc T-cell responses. Mucosal Immunol 1: 475-488.
12. Klatt NR, Brenchley JM (2010) Th17 cell dynamics in HIV infection. Curr Opin HIV AIDS 5: 135-140.
13. Hartigan-O'Connor DJ, Abel K, Van Rompay KK, Kanwar B, McCune JM (2012) SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment. Sci Transl Med 4: 136ra69.
14. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, et al. (2008) Simian immunodefciency virus-induced mucosal interleukin-17 defciency promotes Salmonella dissemination from the gut. Nat Med 14: 421-428.
15. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specifcity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639-646.
16. Aujla SJ, Dubin PJ, Kolls JK (2007) Th17 cells and mucosal host defense. Semin Immunol 19: 377-382.
17. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M (2008) Th17 cytokines and their emerging roles in infammation and autoimmunity. Immunol Rev 226: 87-102.
18. Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281-286.
19. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. (2009) Induction of intestinal Th17 cells by segmented flamentous bacteria. Cell 139: 485-498.
20. Muranski P, Restifo NP (2013) Essentials of Th17 cell commitment and plasticity. Blood 121: 2402-2414.
21. Reynolds JM, Martinez GJ, Nallaparaju KC, Chang SH, Wang YH, et al. (2012) Cutting edge: regulation of intestinal infammation and barrier function by IL-17C. J Immunol 189: 4226-4230.
22. Basu R, O'Quinn DB, Silberger DJ, Schoeb TR, Fouser L, et al. (2012) Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37: 1061-1075.
23. Sonnenberg GF, Fouser LA, Artis D (2011) Border patrol: regulation of immunity, infammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383-390.
24. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
25. De Luca A, Zelante T, D'Angelo C, Zagarella S, Fallarino F, et al. (2010) IL-22 defnes a novel immune pathway of antifungal resistance. Mucosal Immunol 3: 361-373.
26. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, et al. (2009) STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 206: 1465-1472.
27. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281.
28. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289.
29. Fernandes SM, Pires AR, Ferreira C, Foxall RB, Rino J, et al. (2014) Enteric Mucosa Integrity in the Presence of a Preserved Innate Interleukin 22 Compartment in HIV Type 1-Treated Individuals. J Infect Dis.
30. Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, et al. (2013) Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther 15: R136.
31. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) Identifcation of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864-871.
32. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119: 3573-3585.
33. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-863.
34. Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, et al. (2012) A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol 5: 670-680.
35. Ryan-Payseur B, Ali Z, Huang D, Chen CY, Yan L, et al. (2011) Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease. J Infect Dis 204: 1450-1462.
36. Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13: R166.
37. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, et al. (2010) Pathological versus protective functions of IL-22 in airway infammation are regulated by IL-17A. J Exp Med 207: 1293-1305.
38. Ling B, Veazey RS, Luckay A, Penedo C, Xu K, et al. (2002) SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS 16: 1489-1496.
39. Zeng M, Paiardini M, Engram JC, Beilman GJ, Chipman JG, et al. (2012) Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. Blood 120: 1856-1867.
40. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, et al. (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodefciency virus infections. PLoS Pathog 6: e1001052.
41. Cecchinato V, Trindade CJ, Laurence A, Heraud JM, Brenchley JM, et al. (2008) Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodefciency virus-infected macaques. Mucosal Immunol 1: 279-288.
42. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271-2279.
43. Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, et al. (2007) IL-21 initiates an alternative pathway to induce proinfammatory T(H)17 cells. Nature 448: 484-487.
44. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal infammation and acanthosis. Nature 445: 648-651.
45. Rutz S, Eidenschenk C, Ouyang W (2013) IL-22, not simply a Th17 cytokine. Immunol Rev 252: 116-132.
46. Sato W, Aranami T, Yamamura T (2007) Cutting edge: Human Th17 cells are identifed as bearing CCR2+CCR5- phenotype. J Immunol 178: 7525-7529.
47. Douek D (2007) HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 15: 114-117.
48. Ota N, Wong K, Valdez PA, Zheng Y, Crellin NK, et al. (2011) IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol 12: 941-948.
49. Ouyang W, Valdez P (2008) IL-22 in mucosal immunity. Mucosal Immunol 1: 335-338.
50. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, et al. (2010) Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2: 32ra36.
51. Xu H, Wang X, Pahar B, Moroney-Rasmussen T, Alvarez X, et al. (2010) Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodefciency virus-infected macaques and may contribute to T cell dysfunction and disease progression. J Immunol 185: 7340-7348.
52. Xu H, Wang X, Lackner AA, Veazey RS (2013) CD8 down-regulation and functional impairment of SIV-specifc cytotoxic T lymphocytes in lymphoid and mucosal tissues during SIV infection. J Leukoc Biol 93: 943-950.